A decision to offer those under 30 an alternative vaccine to AstraZeneca jab has raised concerns that some may avoid the injection for fear of his safety.
Iain Duncan Smith, the former Tory leader, warned that the Medicines and Health Products Regulatory Agency’s decision to recommend another vaccine for those under 30 could disrupt the UK’s vaccination schedule and play into the hands of anti-vaccination activists.
“This will make it, I’m afraid, more difficult to persuade people to take it, even people over 30 years old.” I don’t understand what they thought they were doing, ”he said. “And these people who are anti-vaxxers are now going to go and say, ‘I told you, we were right.’ It is going to be very difficult and damaging. It plays into the hands of those who do their best to disrupt the immunization program.
The change in the MHRA was “messy, confusing and very unnecessary” and risked compromising “all the hard work GPS do to persuade people, especially those who fear getting the vaccine, to take it, ”added Duncan Smith.
Another Tory MP, who did not want to be named, said: “A significant number of people under the age of 30 will not take the AZ vaccine because of this statement.”
There are signs that recent publicity about the apparent link between the AstraZeneca vaccine and blood clots, in Europe and now in the UK, is dissuading some patients from accepting the vaccine.
A general practitioner said: “People have already consulted about the blood clots worried and decided to wait for more information. As we move towards [vaccinating] for younger age groups, I fear there is more anxiety and uncertainty for patients, and for [GPs], because we are their first point of contact for advice. “
Women who take the combined contraceptive pill might also be reluctant to receive the AZ vaccine, as there was evidence of a slight increased risk of thrombosis, she added. However, there was no guarantee that anyone seeking the Pfizer jab instead of the AZ product would be able to do so, unless the local administration oversight body approved it, he said. she declared.
Ruth Rankine, director of the NHS Confederation’s primary care network, said fear of blood clots did not deter large numbers of people from getting vaccinated. “Our members have not reported a significant impact on the number of people coming for their immunizations, and we hope that by clarifying the recommendations and their rationale, today’s announcement will help build confidence in people in terms of immunization. ”
Professor Martin Marshall, president of the Royal College of General Practitioners, urged people to get the AZ vaccine, including those who are waiting for their second dose.
“It is essential that patients understand that the risk of developing blood clots after receiving the AZ vaccine is incredibly low for all groups of patients,” he said.
Marshall called on ministers and NHS leaders to ensure vaccination sites have enough stocks of Pfizer and Moderna vaccines to be able to vaccinate 18-29 year olds. Rankine agreed, saying, “We will need continued clarity on supplies, regardless of the manufacturer.”
Professor Jonathan Van-Tam, deputy medical director for England, said the MHRA’s new approach – which he called a ‘course correction’ of the vaccination schedule – could cause patients to delay obtaining vaccine or have to travel further for an injection.
Stephen Reicher, a government science adviser, a member of SPI-B, Sage’s behavioral science subgroup, said the confusion currently surrounding the AZ vaccine was in part due to ministers being too positive about blows that the United Kingdom has deployed.
“The difficulty is, if you overestimate positivity, then when there are problems it looks like you were wrong, you were wrong,” he said.
He added: “It’s a uplifting tale that says ‘be transparent’ – don’t overdo it, the vaccines are positive enough like that, don’t overestimate that. We need to be transparent from now on and recognize that people are mature enough to balance risks all the time, and overall not much has changed. Let’s not fabricate a crisis out of the situation we find ourselves in. “
Professor Saad Shakir, director of the Medicines Safety Research Unit at the University of Southampton, said the MHRA’s decision to recommend other vaccines for those under 30 was a “welcome and suitably cautious” gesture. “I appreciate that this news will cause concern for some people. I would like to reiterate that these events are very rare and I hope people can take comfort in knowing that rigorous and meticulous research and monitoring is being done on possible side effects.
Worried AstraZeneca Jab May Play In Anti-Vaxxers, Tories Say | Coronavirus
Source link Worried AstraZeneca Jab May Play In Anti-Vaxxers, Tories Say | Coronavirus